GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroGen Inc (MEX:FGEN) » Definitions » Purchase Of Investment

FibroGen (MEX:FGEN) Purchase Of Investment : MXN-1,749 Mil (TTM As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is FibroGen Purchase Of Investment?

FibroGen's purchase of investment for the three months ended in Sep. 2024 was MXN0 Mil. It means FibroGen spent MXN0 Mil on purchasing investments. FibroGen's purchase of investment for the trailing twelve months (TTM) ended in Sep. 2024 was MXN-1,749 Mil.

Compared with last quarter (MXN0 Mil in Jun. 2024 ), FibroGen spent the same money on purchasing investments in Sep. 2024 (MXN0 Mil).

FibroGen Purchase Of Investment Historical Data

The historical data trend for FibroGen's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroGen Purchase Of Investment Chart

FibroGen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7,757.10 -162.96 -9,931.73 -3,197.79 -4,274.63

FibroGen Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -917.40 -1,606.10 -143.19 - -

FibroGen Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-1,749 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FibroGen Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of FibroGen's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

FibroGen Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroGen Inc (MEX:FGEN) » Definitions » Purchase Of Investment
Comparable Companies
KRON CRDF CTCX AFMD CRVO RANI IPA COYA CASI BIOR OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
FGEN:USA 0IL8:UK 1FG:Germany
Address
409 Illinois Street, San Francisco, CA, USA, 94158
Website
https://www.fibrogen.com
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.